Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial
- 4 July 2023
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 63 (5) , 507-518
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Planning Project of Guangdong Province (2019B030316001)
- Basic and Applied Basic Research Foundation of Guangdong Province (2019A1515011366, 2022A1515011567)
This publication has 32 references indexed in Scilit:
- Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous KetamineThe Journal of Clinical Psychiatry, 2016
- Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week studyPsychological Medicine, 2015
- Concomitant Benzodiazepine Use Attenuates Ketamine ResponseJournal of Clinical Psychopharmacology, 2015
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodesPsychological Medicine, 2014
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled TrialAmerican Journal of Psychiatry, 2013
- Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open QuestionsCNS Neuroscience & Therapeutics, 2013
- The European Psychiatric Association (EPA) guidance on suicide treatment and preventionEuropean Psychiatry, 2012
- Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS)Journal of Traumatic Stress, 1998
- The Brief Psychiatric Rating ScalePsychopathology, 1989
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978